SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-195481
Filing Date
2020-07-20
Accepted
2020-07-20 16:15:35
Documents
14
Period of Report
2020-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d120197d8k.htm   iXBRL 8-K 31357
2 EX-99.1 d120197dex991.htm EX-99.1 28942
3 EX-99.2 d120197dex992.htm EX-99.2 37271
  Complete submission text file 0001193125-20-195481.txt   241822

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA acad-20200720.xsd EX-101.SCH 3082
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE acad-20200720_lab.xml EX-101.LAB 18139
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acad-20200720_pre.xml EX-101.PRE 11416
7 EXTRACTED XBRL INSTANCE DOCUMENT d120197d8k_htm.xml XML 3417
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

IRS No.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50768 | Film No.: 201036596
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences